University Malaysia Sarawak
18
2
2
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 18 trials
100.0%
+13.5% vs industry average
11%
2 trials in Phase 3/4
0%
0 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Otago Exercise Programme and Physical Function in Older Adults in Sarawak
Role: lead
Anatomical Determinants and Outcomes of Small Annulus Patients Undergoing TAVR in Different ASIAN Ethnicity
Role: collaborator
Promoting Mental Health Among At-risk Adolescents in Malaysia
Role: collaborator
Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea
Role: lead
Comparison of MedBook Portal and Usual Care in Medication Reconciliation at Primary Healthcare Upon Hospital Discharge
Role: collaborator
Effectiveness of Ultrasound-guided Scalp Block for Supratentorial Craniotomy
Role: lead
The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers
Role: lead
Translation and Validation of Malay Version of painDETECT Questionnaire
Role: lead
Vitamin D Levels and Heart Rate Variability on Endothelial Function Via RAAS Augmentation in OSA
Role: lead
Establishment of Aldosterone and Renin Reference Range
Role: lead
Single Session of 30-Minute Mindful Breathing in Reducing Fatigue
Role: lead
The Immediate Effect of Mindfulness-Based Supportive Therapy on Palliating Suffering in Palliative Care Cancer Patients
Role: lead
DPP4 Inhibitor on Glycemic Variability
Role: lead
Effects of Calamansi on Blood Glucose
Role: lead
Effectiveness of an Intervention in Improving Medication Adherence Among Malay Patients With Underlying Type 2 Diabetes Mellitus in Malaysia
Role: collaborator
The Effect of Obesity on Pregnancy and Fetal Outcome in Glucose Tolerant Mothers
Role: lead
Antibiotic Prophylaxis in Ragged Placental Membranes
Role: collaborator
The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
Role: lead
All 18 trials loaded